Antonella Montanini

ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial

Massimo Federico, Stefano Luminari, Emilio Iannitto et al. · Journal of Clinical Oncology · 2009 · 270 citations · Full text

Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial

Stefano Luminari, Antonella Montanini, Dolores Caballero et al. · Annals of Oncology · 2009 · 92 citations · Full text

Incidence, clinical characteristics and survival of malignant lymphomas: a population‐based study from a cancer registry in northern Italy

Stefano Luminari, Marina Cesaretti, Ivan Rashid et al. · Hematological Oncology · 2007 · 60 citations

Long-Term Follow-Up Analysis of HD9601 Trial Comparing ABVD Versus Stanford V Versus MOPP/EBV/CAD in Patients With Newly Diagnosed Advanced-Stage Hodgkin's Lymphoma: A Study From the Intergruppo Italiano Linfomi

Teodoro Chisesi, Monica Bellei, Stefano Luminari et al. · Journal of Clinical Oncology · 2011 · 53 citations

Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)

Nicola Di Renzo, Antonella Montanini, Donato Mannina et al. · Supportive Care in Cancer · 2010 · 26 citations · Full text